Presently, the research & development by business enterprise, pharmaceutical industry in constant ppp $ in Canada stands at 483.26 million, an increase of 89.74 million (22.8%) since 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Canada
No matching regions
Similar regions to Canada
Business R&D pharmaceutical in constant PPP $
More indicators for Canada
Government R&D in security as % of government support
2.59%
+0.27%
(2021)
Higher-education-finacing R&D financed by general university in local currency
38,070.00M
+380.00M
(2023)
R&D financed by rest of the world in local currency
51,800.00M
+1,210.00M
(2023)
Government R&D financed by rest of the world in local currency
10.00M
0.00M
(2023)
Business R&D financed by rest of the world in local currency
50,210.00M
+1,190.00M
(2023)
Non-profit R&D growth rate
-14.23%
-23.4%
(2022)
Canada Business R&D pharmaceutical in constant PPP $ between 1994 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 483.26M | +89.74M |
| 2020 | 393.52M | +19.78M |
| 2019 | 373.75M | -49.37M |
| 2018 | 423.11M | -6.12M |
| 2017 | 429.23M | +36.15M |
| 2016 | 393.08M | -7.55M |
| 2015 | 400.63M | +24.98M |
| 2014 | 375.64M | +28.34M |
| 2013 | 347.30M | -35.76M |
| 2012 | 383.06M | -62.30M |
| 2011 | 445.36M | -141.79M |
| 2010 | 587.15M | -10.02M |
| 2009 | 597.16M | -7.14M |
| 2008 | 604.30M | -291.69M |
| 2007 | 895.99M | -124.62M |
| 2006 | 1,020.61M | -5.21M |
| 2005 | 1,025.82M | -84.44M |
| 2004 | 1,110.25M | +50.49M |
| 2003 | 1,059.76M | -120.69M |
| 2002 | 1,180.46M | +251.04M |
| 2001 | 929.42M | +112.74M |
| 2000 | 816.68M | +185.55M |
| 1999 | 631.13M | +103.33M |
| 1998 | 527.80M | +35.76M |
| 1997 | 492.04M | -25.91M |
| 1996 | 517.95M | +37.30M |
| 1995 | 480.65M | +48.39M |
| 1994 | 432.25M |